Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1.75	2.23	2.52	3.53	3.93	1.76
Revenue Growth (YoY)	-35.55%	-11.61%	-28.54%	-10.18%	122.86%	-
Cost of Revenue	6.57	7.59	19.84	4.69	4.39	3.4
Gross Profit	-4.82	-5.36	-17.31	-1.16	-0.46	-1.64
Selling, General & Admin	5.18	5.36	6.91	18.71	1.15	6.93
Operating Expenses	5.18	5.36	6.91	18.71	1.15	6.93
Operating Income	-10	-10.72	-24.22	-19.87	-1.61	-8.57
Interest Expense	-1.6	-0.35	-1.25	-3.22	-1	-0.96
Other Non Operating Income (Expenses)	0.05	0.3	-0.53	-2.91	2.45	-0.58
EBT Excluding Unusual Items	-11.55	-10.77	-26	-26	-0.16	-10.1
Other Unusual Items	-	0.15	1.79	-3.15	-	-
Pretax Income	-11.55	-10.63	-24.21	-29.15	-0.16	-10.1
Earnings From Continuing Operations	-11.55	-10.63	-24.21	-29.15	-0.16	-10.1
Minority Interest in Earnings	0.01	0.01	0.04	0.06	0.22	-
Net Income	-11.54	-10.61	-24.17	-29.08	0.06	-10.1
Preferred Dividends & Other Adjustments	0	0.01	0.91	0.8	-	-
Net Income to Common	-11.55	-10.63	-25.09	-29.89	0.06	-10.1
Shares Outstanding (Basic)	3	2	0	0	0	1
Shares Outstanding (Diluted)	3	2	0	0	0	1
Shares Change (YoY)	724.99%	1158.34%	114.15%	22.15%	-93.11%	-
EPS (Basic)	-3.37	-4.69	-139.42	-355.72	0.86	-10.12
EPS (Diluted)	-3.38	-4.69	-139.42	-355.72	0.84	-10.12
Free Cash Flow	-10.58	-10.78	-17.89	-8.24	-1.25	-0.94
Free Cash Flow Per Share	-3.09	-4.76	-99.42	-98.10	-18.13	-0.94
Gross Margin	-276.18%	-240.17%	-	-32.82%	-11.66%	-92.88%
Operating Margin	-572.53%	-480.52%	-959.91%	-562.71%	-41.04%	-485.74%
Profit Margin	-	-	-	-	1.44%	-
Free Cash Flow Margin	-605.83%	-483.29%	-708.87%	-233.41%	-31.73%	-53.02%
EBITDA	-	-	-24.22	-19.87	-1.61	-8.57
EBITDA Margin	-	-	-	-	-41.03%	-
D&A For EBITDA	-	-	0	0	0	0
EBIT	-10	-10.72	-24.22	-19.87	-1.61	-8.57
EBIT Margin	-	-	-	-	-41.04%	-

Source: S&P Capital IQ. Standard template.